| 注册
首页|期刊导航|时珍国医国药|补肾活血泄浊方调节Keap1/Nrf2/HO-1介导的铁死亡改善慢性肾衰竭大鼠纤维化的机制研究

补肾活血泄浊方调节Keap1/Nrf2/HO-1介导的铁死亡改善慢性肾衰竭大鼠纤维化的机制研究

吴振华 刘靖薇 王欣冉 闫晓欢 檀淼 陈素枝 檀金川 杨凤文 任美芳

时珍国医国药2026,Vol.37Issue(8):1439-1447,9.
时珍国医国药2026,Vol.37Issue(8):1439-1447,9.DOI:10.70976/j.1008-0805.SZGYGY-2026-0805

补肾活血泄浊方调节Keap1/Nrf2/HO-1介导的铁死亡改善慢性肾衰竭大鼠纤维化的机制研究

Bushen Huoxue Xiezhuo Formula(补肾活血泄浊方)regulates ferroptosis mediated by Keap1/Nrf2/HO-1 to reduce renal fibrosis in rats with chronic renal failure

吴振华 1刘靖薇 1王欣冉 1闫晓欢 1檀淼 2陈素枝 3檀金川 3杨凤文 3任美芳3

作者信息

  • 1. 河北中医药大学,河北 石家庄 050200
  • 2. 河北医科大学第四医院,河北 石家庄 050000
  • 3. 河北省中医院,河北 石家庄 050011
  • 折叠

摘要

Abstract

Objective To evaluate the effects of Bushen Huoxue Xiezhuo Formula(补肾活血泄浊方,BHXF)in a rat model of chronic renal failure(CRF)and investigate its potential anti-renal fibrosis mechanism related to the ferroptosis pathway mediated by Keap1/Nrf2/HO-1.Methods Ninety male SD rats were randomly divided into six groups(n=15 per group):the sham-operated group,model group,low/medium/high-dose BHXF group(5.31 g·kg-1·d-1,10.62 g·kg-1·d-1,21.24 g·kg-1·d-1),and the benazepril group(10 mg·kg-1·d-1).Rats received the corresponding doses of BHXF or benazepril by gavage once daily for 8 weeks;the sham-operated and model groups received an equivalent volume of physiological saline.After the experiment,kidney tissues were collected for histological exami-nation(HE and Masson staining)to assess renal injury and fibrosis under light microscopy.Serum levels of urea nitrogen(Urea),serum creatinine(SCr),and β2-MG were measured using an automated biochemical analyzer.Serum ROS,SOD,and MDA levels were detected by ELISA.Immunohistochemistry(IHC)was used to detect the expression of α-SMA,TGF-β,FN,Collagen-I,SLC7A11,and GPX4 in renal tissues.Western blot(WB)was performed to analyze the protein expression of Keap1,Nrf2,and HO-1.The mRNA expression levels of Keap1,Nrf2,HO-1,SLC7A11,and GPX4 were quantified by real-time reverse transcription poly-merase chain reaction(RT-PCR).Results Compared with the sham-operated group,the model group exhibited significant pathological alterations,including marked renal tubular dilation and collagen deposition.The model group also showed increased levels of Urea,SCr,β2-MG,ROS,MDA,α-SMA,TGF-β,FN,Collagen-I,and Keap1 protein(P<0.05),alongside decreased levels of SOD,Nrf2 protein,HO-1 protein,GPX4 protein,and SLC7A11 protein(P<0.05).Drug interventions ameliorated the pathological changes and reduced fibrosis(P<0.05).Treated groups exhibited decreased levels of Urea,SCr,β2-MG,ROS,MDA,α-SMA,TGF-β,FN,Collagen-I,and Keap1 protein(P<0.05),and increased levels of SOD,Nrf2 protein,HO-1 protein,GPX4 protein,and SLC7A11 protein(P<0.05).The high-dose BHXF group demonstrated the most pronounced effects(P<0.05).Conclusion BHXF effectively attenuated renal fibrosis and improved renal function in CRF rats.Its underlying mechanism may involve regulating the Keap1/Nrf2/HO-1 signaling pathway to inhibit ferroptosis.

关键词

慢性肾衰竭/补肾活血泄浊方/铁死亡/纤维化/Keap1/Nrf2/HO-11通路

Key words

Chronic renal failure/Bushen Huoxue Xiezhuo Formula(补肾活血泄浊方)/Ferroptosis/Fibrosis/Keap1/Nrf2/HO-1 pathway

分类

医药卫生

引用本文复制引用

吴振华,刘靖薇,王欣冉,闫晓欢,檀淼,陈素枝,檀金川,杨凤文,任美芳..补肾活血泄浊方调节Keap1/Nrf2/HO-1介导的铁死亡改善慢性肾衰竭大鼠纤维化的机制研究[J].时珍国医国药,2026,37(8):1439-1447,9.

基金项目

国家自然科学基金(82405075) (82405075)

河北省自然科学基金(2021423050) (2021423050)

河北省政府优才项目(ZF2024165) (ZF2024165)

国家中医临床研究基地项目 ()

河北省脾肾病证中医治疗技术创新中心项目 ()

时珍国医国药

1008-0805

访问量0
|
下载量0
段落导航相关论文